A1ZN34:BVMF
Astrazeneca Plc Bdr
R$ 139.90
0.00%
(0.00) Siku 1
16 Okt, 17:06:00 GMT -3 · BRL
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya A1ZN34...
Fungua
R$ 143.33
Juu
R$ 143.33
Chini
R$ 138.81
Mtaji wa soko
259.42B
Wastani wa kiasi cha mauzo
892.00
Kiasi cha mauzo ya hisa
elfu 1.25
Juu kwa wiki 52
R$ 190.40
Chini kwa wiki 52
R$ 129.06
Hisa za wawekezaji
1.55B
Idadi ya wafanyakazi
elfu 96
Fungua
R$ 143.33
Juu
R$ 143.33
Chini
R$ 138.81
Mtaji wa soko
259.42B
Wastani wa kiasi cha mauzo
892.00
Kiasi cha mauzo ya hisa
elfu 1.25
Juu kwa wiki 52
R$ 190.40
Chini kwa wiki 52
R$ 129.06
Hisa za wawekezaji
1.55B
Idadi ya wafanyakazi
elfu 96
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
The Twelfth Magpie
·
siku 2 zilizopita
While the market panics about the FTSE 100, Citi just raised its AstraZeneca target to £186
JournalArta
·
siku 2 zilizopita
AstraZeneca Stock Analysis: Gains 3.24%, Testing Key Resistance
BioSpace
·
siku 3 zilizopita
AstraZeneca bulks up MASH, cardio work in up to $1.5B AI partnership with insitro
Wasifu
AstraZeneca plc is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, England; Gothenburg, Sweden; and Gaithersburg, Maryland, US.
AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Wikipedia
Kuhusu Astrazeneca Plc Bdr
Afisa Mkuu Mtendaji (CEO)Pascal Soriot
Wafanyakazielfu 96.1
Lilianzishwa6 Apr 1999
Makao makuuCambridge, Cambridgeshire, Uingereza
Sekta-
Tovutiastrazeneca.com